Santen Pharmaceutical Co., Ltd. Share Price Deutsche Boerse AG
Stocks
SZD
JP3336000009
Pharmaceuticals
OTC Markets Traded|
Real-time Estimate
Tradegate
12:25:30 26/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 10.08 EUR | +2.28% |
|
-1.01% | +13.22% |
| 08-06 | Santen Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| 07-27 | Glaukos' Trial of Preserflo MicroShunt Completes Enrollment | MT |
| Market Cap | 602B 3.78B 3.24B 3.04B 2.77B 5.23B 360B 5.28B 35.81B 13.94B 182B 14.2B 13.89B | P/E 2027 * |
15.7x | P/E 2028 * | 14.1x |
|---|---|---|---|---|---|
| Enterprise Value | 555B 3.49B 2.99B 2.8B 2.56B 4.83B 332B 4.87B 33.03B 12.86B 168B 13.09B 12.81B | EV / Sales 2027 * |
1.83x | EV / Sales 2028 * | 1.71x |
| Free-Float |
96.71% | Yield 2027 * |
2.23% | Yield 2028 * | 2.49% |
| 29/09/23 | ETF der Woche: Back to the Roots | |
| 28/09/23 | ETF van de week: terug naar de basis | |
| 28/09/23 | L'ETF della settimana: ritorno ai fondamentali | |
| 28/09/23 | ETF de la semaine : Retour aux fondamentaux | |
| 15/02/21 | Nicox S A : A suivre aujourd'hui |
| 1 day | +2.28% | ||
| 1 week | -1.01% | ||
| Current month | -2.48% | ||
| 1 month | -4.37% | ||
| 3 months | -4.37% | ||
| 6 months | +5.91% | ||
| Current year | +13.22% |
| 1 week | 9.85 |  | 10.4 |
| 1 month | 9.85 | | 10.7 |
| Current year | 8.3 | | 11.9 |
| 1 year | 8.05 | | 11.9 |
| 3 years | 7.75 | | 11.9 |
| 5 years | 6.4 | | 13.5 |
| 10 years | 6.4 | | 18.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Takeshi Ito
CEO | Chief Executive Officer | 67 | 31/08/2022 |
Kazuo Koshiji
DFI | Director of Finance/CFO | - | - |
Daisuke Nakata
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Takeshi Ito
BRD | Director/Board Member | 67 | 22/06/2017 |
Ippei Kurihara
BRD | Director/Board Member | 45 | 31/05/2024 |
Rie Nakajima
BRD | Director/Board Member | 48 | 31/05/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.28% | -1.01% | - | - | 3.78B | |
| -1.06% | +0.65% | +77.42% | +122.82% | 1,100B | |
| +0.04% | +0.75% | +53.10% | +64.29% | 658B | |
| +0.48% | +2.65% | +28.06% | +81.19% | 470B | |
| -0.60% | +1.09% | +43.29% | +43.31% | 372B | |
| -0.36% | +0.55% | +26.20% | +41.30% | 304B | |
| -1.14% | +2.13% | +3.66% | +13.91% | 264B | |
| -0.36% | +3.99% | +53.31% | +72.49% | 239B | |
| +0.27% | +3.12% | -12.01% | -52.24% | 213B | |
| +1.38% | +3.72% | +30.33% | +93.56% | 184B | |
| Average | +0.22% | +3.01% | +33.71% | +53.41% | 422.54B | |
| Weighted average by Cap. | +0.07% | +2.21% | +45.77% | +71.35% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 304B 1.91B 1.63B 1.53B 1.4B 2.64B 182B 2.66B 18.05B 7.03B 91.66B 7.16B 7B | 314B 1.97B 1.69B 1.58B 1.45B 2.73B 188B 2.76B 18.69B 7.28B 94.91B 7.41B 7.25B |
| Net income | 37.98B 238M 204M 191M 175M 330M 22.73B 333M 2.26B 879M 11.47B 895M 876M | 41.31B 259M 222M 208M 190M 359M 24.72B 363M 2.46B 956M 12.47B 974M 953M |
| Net Debt | -46.74B -293M -251M -236M -215M -406M -27.98B -410M -2.78B -1.08B -14.11B -1.1B -1.08B | -63.67B -400M -342M -321M -293M -553M -38.1B -559M -3.79B -1.47B -19.22B -1.5B -1.47B |
| Date | Price | Change |
|---|---|---|
| 26/08/26 | €9.850 | 0.00% |
| 25/08/26 | €9.850 | 0.00% |
| 24/08/26 | €9.850 | 0.00% |
| 21/08/26 | €9.850 | -5.29% |
| 20/08/26 | €10.40 | +4.52% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4536 Stock
- SZD Stock
Select your edition
All financial news and data tailored to specific country editions
